Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Aliasgharian A"'
Autor:
Hossein Jalali, Mohammad Reza Mahdavi, Mehrnoush Kosaryan, Ahmad Najafi, Aily Aliasgharian, Ebrahim Salehifar
Publikováno v:
Thalassemia Reports, Vol 14, Iss 3, Pp 71-80 (2024)
HbF induction is an appropriate strategy to ameliorate the severity of β-thalassemia symptoms. Hydroxyurea (HU) is the most common chemical agent introduced as an HbF inducer but responsiveness to HU is variable and the introduction of HbF inducers
Externí odkaz:
https://doaj.org/article/28040da465084f7b966b7a8289701c21
Autor:
Mobin Ghazaiean, Aily Aliasgharian, Hossein Karami, Mohammad Mohsen Ghasemi, Hadi Darvishi‐Khezri
Publikováno v:
Health Science Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)
Abstract Background and Aims Several studies have highlighted the potent antioxidant properties of N‐acetyl cysteine (NAC). This review aimed to assess the impact of NAC on oxidative stress biomarkers in patients with β‐thalassemia. Methods The
Externí odkaz:
https://doaj.org/article/bb26f2a688664354b00c25f2ff3098eb
Autor:
Aily Aliasgharian, Hossein Karami, Mohammad Zahedi, Reza Jahanshahi, Hossein Bakhtiari-Dovvombaygi, Amirreza Nasirzadeh, Mohammad Naderisorki, Mehrnoush Kosaryan, Ebrahim Salehifar, Mobin Ghazaiean, Saeid Bitaraf, Hadi Darvishi-Khezri
Publikováno v:
Thalassemia Reports, Vol 13, Iss 4, Pp 241-252 (2023)
Background and aim: We conducted a review to determine the efficacy of amlodipine alongside iron chelators on serum ferritin levels and liver T2-weighted magnetic resonance imaging (MRI T2*) in β-thalassemia patients. Methods: Systematic search was
Externí odkaz:
https://doaj.org/article/518ba1e7f83b47008fa7d2b7e7bc958d
Autor:
Hossein Karami, Mehrnoush Kosaryan, Mohammad Naderisorki, Fatemeh esfandiari, Mobin Ghazaiean, Aily Aliasgharian, Hanie Fallah, Salameh Shakeri, Hadi Darvishi-Khezri
Publikováno v:
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, Vol 31, Iss 6, Pp 6732-6745 (2023)
Introduction: OsteoPenia and osteoPorosis are known to be one of the main comPlications of β-thalassemia major (β-TM). The aim of this study was to determine the factors associated with decreased bone density of these Patients. Methods: Lumbar and
Externí odkaz:
https://doaj.org/article/b8dac6c5fb8d4283af5cca60498c266a
Autor:
Aliasgharian, Aily1 aily.aliasgharian@gmail.com, Karami, Hossein1 karami_oncologist@yahoo.com, Zahedi, Mohammad2 mohammadzhd9435@yahoo.com, Jahanshahi, Reza3 rjahanshahi75@yahoo.com, Bakhtiari-Dovvombaygi, Hossein4 hs.bakhtiari1998@gmail.com, Nasirzadeh, Amirreza5 nasirzadeharnz@gmail.com, Naderisorki, Mohammad1 dr.naderisorki@gmail.com, Kosaryan, Mehrnoush1 mekowsarian@gmail.com, Salehifar, Ebrahim6 esalehifar52@gmail.com, Ghazaiean, Mobin7 dr.mobin.gh@gmail.com, Bitaraf, Saeid8 drsbitaraf@yahoo.com, Darvishi-Khezri, Hadi1 hadidarvishi87@gmail.com
Publikováno v:
Thalassemia Reports. Dec2023, Vol. 13 Issue 4, p241-252. 12p.
Publikováno v:
Open Medicine, Vol 18, Iss 1, Pp 479-89 (2023)
Iron-overload-associated cardiomyopathy has been one of the primary causes of mortality in thalassemia patients with iron burden. There is growing evidence citing the beneficial effects of ebselen as an antioxidant selectively blocking the divalent m
Externí odkaz:
https://doaj.org/article/d6b7bbb7b92849a4a755e1c003940eaf
Autor:
Hadi Darvishi-Khezri, Hossein Karami, Mohammad Naderisorki, Mobin Ghazaiean, Mehrnoush Kosaryan, Amir Mosanejad-Galchali, Aily Aliasgharian, Hasan Karami
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0284267 (2024)
Background and aimHypozincemia is a prevalent adverse consequence in diabetes mellitus (DM) and β-Thalassemia patients. We aimed to evaluate the level of serum zinc in β-thalassemia patients with DM and a risk assessment for hypozincemia.MethodsThe
Externí odkaz:
https://doaj.org/article/33f8e71d598843998b66aeb927e96ed7
Autor:
Hadi Darvishi-Khezri, Aily Aliasgharian, Mohammad Naderisorki, Mehrnoush Kosaryan, Mobin Ghazaiean, Hanie Fallah, Mohammad Zahedi, Hossein Karami
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Ferritin is frequently used to screen some dire consequences of iron overload in β-thalassemia patients. The study aimed to define the best cutoff point of ferritin to screen for cardiac and liver hemosiderosis in these cases. This was a re
Externí odkaz:
https://doaj.org/article/e8580ee430864564a8a432118c41d465
Autor:
Ghazaiean, Mobin, Aliasgharian, Aily, Karami, Hossein, Ghasemi, Mohammad Mohsen, Darvishi‐Khezri, Hadi
Publikováno v:
Health Science Reports; Oct2024, Vol. 7 Issue 10, p1-16, 16p
Autor:
Jalali, Hossein, Mahdavi, Mohammad Reza, Kosaryan, Mehrnoush, Najafi, Ahmad, Aliasgharian, Aily, Salehifar, Ebrahim
Publikováno v:
Thalassemia Reports; Sep2024, Vol. 14 Issue 3, p71-80, 10p